Italy
· Delayed Price · Currency is EUR FF Statistics
Total Valuation
Fine Foods & Pharmaceuticals N.T.M. has a market cap or net worth of EUR 203.20 million. The enterprise value is 250.24 million.
| Market Cap | 203.20M |
| Enterprise Value | 250.24M |
Important Dates
The next estimated earnings date is Friday, September 20, 2024.
| Earnings Date | Sep 20, 2024 |
| Ex-Dividend Date | Jun 3, 2024 |
Share Statistics
Fine Foods & Pharmaceuticals N.T.M. has 24.48 million shares outstanding. The number of shares has increased by 12.07% in one year.
| Shares Outstanding | 24.48M |
| Shares Change (YoY) | +12.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 7.98% |
| Float | 11.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.80 |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | 21.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.85, with an EV/FCF ratio of 26.44.
| EV / Earnings | -69.31 |
| EV / Sales | 0.99 |
| EV / EBITDA | 10.85 |
| EV / EBIT | 36.29 |
| EV / FCF | 26.44 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 46.99.
| Current Ratio | 1.65 |
| Quick Ratio | 0.92 |
| Debt / Equity | 46.99 |
| Debt / EBITDA | 2.64 |
| Debt / FCF | 6.44 |
| Interest Coverage | 1.43 |
Financial Efficiency
Return on equity (ROE) is -2.72% and return on invested capital (ROIC) is 1.93%.
| Return on Equity (ROE) | -2.72% |
| Return on Assets (ROA) | 1.56% |
| Return on Capital (ROIC) | 1.93% |
| Revenue Per Employee | 334,417 |
| Profits Per Employee | -4,795 |
| Employee Count | 753 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 4.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.24% in the last 52 weeks. The beta is 0.68, so Fine Foods & Pharmaceuticals N.T.M.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +0.24% |
| 50-Day Moving Average | 8.65 |
| 200-Day Moving Average | 8.59 |
| Relative Strength Index (RSI) | 47.68 |
| Average Volume (20 Days) | 2,501 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Fine Foods & Pharmaceuticals N.T.M. had revenue of EUR 251.82 million and -3.61 million in losses.
| Revenue | 251.82M |
| Gross Profit | 69.78M |
| Operating Income | 6.90M |
| Pretax Income | -2.15M |
| Net Income | -3.61M |
| EBITDA | 21.99M |
| EBIT | 6.90M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 13.89 million in cash and 60.92 million in debt, giving a net cash position of -47.04 million or -1.92 per share.
| Cash & Cash Equivalents | 13.89M |
| Total Debt | 60.92M |
| Net Cash | -47.04M |
| Net Cash Per Share | -1.92 |
| Equity (Book Value) | 129.65M |
| Book Value Per Share | n/a |
| Working Capital | 43.33M |
Cash Flow
In the last 12 months, operating cash flow was 28.31 million and capital expenditures -18.84 million, giving a free cash flow of 9.46 million.
| Operating Cash Flow | 28.31M |
| Capital Expenditures | -18.84M |
| Free Cash Flow | 9.46M |
| FCF Per Share | 0.39 |
Margins
Gross margin is 27.71%, with operating and profit margins of 2.74% and -1.43%.
| Gross Margin | 27.71% |
| Operating Margin | 2.74% |
| Pretax Margin | -0.85% |
| Profit Margin | -1.43% |
| EBITDA Margin | 8.73% |
| EBIT Margin | 2.74% |
| FCF Margin | 3.76% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 1.46%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 1.46% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.07% |
| Shareholder Yield | -10.61% |
| Earnings Yield | n/a |
| FCF Yield | 4.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |